CO6821959A2 - Formas de dosificación farmacéutica intranasales que comprenden naloxona - Google Patents

Formas de dosificación farmacéutica intranasales que comprenden naloxona

Info

Publication number
CO6821959A2
CO6821959A2 CO13291649A CO13291649A CO6821959A2 CO 6821959 A2 CO6821959 A2 CO 6821959A2 CO 13291649 A CO13291649 A CO 13291649A CO 13291649 A CO13291649 A CO 13291649A CO 6821959 A2 CO6821959 A2 CO 6821959A2
Authority
CO
Colombia
Prior art keywords
naloxone
dosage forms
pharmaceutical dosage
intranasal pharmaceutical
intranasal
Prior art date
Application number
CO13291649A
Other languages
English (en)
Inventor
John Strang
Alexander Oksche
Stephen Harris
Kevin Smith
Lucie Helene Jeanne Mottier
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44658496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6821959(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of CO6821959A2 publication Critical patent/CO6821959A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
CO13291649A 2011-05-13 2013-12-13 Formas de dosificación farmacéutica intranasales que comprenden naloxona CO6821959A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11166076 2011-05-13

Publications (1)

Publication Number Publication Date
CO6821959A2 true CO6821959A2 (es) 2013-12-31

Family

ID=44658496

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13291649A CO6821959A2 (es) 2011-05-13 2013-12-13 Formas de dosificación farmacéutica intranasales que comprenden naloxona

Country Status (36)

Country Link
US (7) US20150018379A1 (es)
EP (2) EP2706982B2 (es)
JP (3) JP6110367B2 (es)
KR (2) KR101873174B1 (es)
CN (2) CN103764119A (es)
AR (1) AR086391A1 (es)
AT (1) AT16553U1 (es)
AU (2) AU2012257785B2 (es)
BR (1) BR112013029126A2 (es)
CA (1) CA2835940C (es)
CO (1) CO6821959A2 (es)
CY (1) CY1120399T1 (es)
DE (1) DE202012013606U1 (es)
DK (2) DK2706982T4 (es)
ES (1) ES2661838T5 (es)
HK (1) HK1255428A1 (es)
HR (1) HRP20180233T1 (es)
HU (1) HUE036465T2 (es)
IL (1) IL229409B (es)
LT (1) LT2706982T (es)
ME (1) ME02958B (es)
MX (1) MX354249B (es)
MY (1) MY194947A (es)
NO (1) NO2706982T3 (es)
PH (1) PH12016501342B1 (es)
PL (1) PL2706982T3 (es)
PT (1) PT2706982T (es)
RS (1) RS57054B1 (es)
RU (2) RU2587051C2 (es)
SG (1) SG194927A1 (es)
SI (1) SI2706982T1 (es)
TR (1) TR201802716T4 (es)
TW (1) TWI486161B (es)
UA (1) UA110974C2 (es)
WO (1) WO2012156317A2 (es)
ZA (1) ZA201308280B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8627816B2 (en) 2011-02-28 2014-01-14 Intelliject, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
US8939943B2 (en) 2011-01-26 2015-01-27 Kaleo, Inc. Medicament delivery device for administration of opioid antagonists including formulations for naloxone
AR086391A1 (es) * 2011-05-13 2013-12-11 Euro Celtique Sa Formas de dosificacion farmaceutica intranasales que comprenden naloxona
CA2875384A1 (en) 2013-12-20 2015-06-20 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
CN106163499A (zh) 2014-03-14 2016-11-23 欧皮安特制药有限公司 鼻用药物产品及其使用方法
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
US11135155B2 (en) * 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
US10722510B2 (en) 2014-07-08 2020-07-28 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
CA2954637A1 (en) * 2014-07-09 2016-01-14 Opiant Pharmaceuticals, Inc. Co-packaged drug products
US9517307B2 (en) 2014-07-18 2016-12-13 Kaleo, Inc. Devices and methods for delivering opioid antagonists including formulations for naloxone
US11559483B2 (en) * 2015-07-10 2023-01-24 Sanjay Gupta Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene
WO2017049181A1 (en) * 2015-09-17 2017-03-23 Adapt Pharma Limited Nasal drug products and methods of their use
KR102453781B1 (ko) * 2016-06-24 2022-10-12 오피언트 파마슈티컬스, 인코퍼레이티드 알코올 사용 장애의 치료용 조성물, 장치 및 방법
CA3033897C (en) 2016-08-17 2024-03-26 Insys Development Company, Inc. Liquid naloxone spray
EP3946547A4 (en) 2019-03-26 2023-01-18 Pocket Naloxone Corp. DEVICES AND METHODS FOR DELIVERING PHARMACEUTICAL COMPOSITIONS
CA3134943A1 (en) * 2019-03-26 2020-10-01 Pocket Naloxone Corp. Devices and methods for delivering pharmaceutical compositions
US10729687B1 (en) 2019-07-09 2020-08-04 Orexo Ab Pharmaceutical composition for nasal delivery
US10653690B1 (en) * 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
WO2021222545A1 (en) * 2020-04-29 2021-11-04 The Texas A&M University System Naloxone nanoparticle compositions and methods thereof
KR20230012502A (ko) 2020-05-18 2023-01-26 오렉쏘 에이비 약물 전달을 위한 신규한 약학 조성물
US11278709B1 (en) 2021-03-12 2022-03-22 Pocket Naloxone Corp. Drug delivery device and methods for using same
AR127780A1 (es) 2021-11-25 2024-02-28 Orexo Ab Nueva composición farmacéutica que comprende adrenalina

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) * 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
GB9202464D0 (en) 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
US5866154A (en) * 1994-10-07 1999-02-02 The Dupont Merck Pharmaceutical Company Stabilized naloxone formulations
US6608073B1 (en) 1998-10-14 2003-08-19 New Millennium Pharmaceutical Research, Inc. Intranasal codeine for the rapid suppression of cough and rapid relief of pain
GB9908921D0 (en) * 1999-04-19 1999-06-16 Britannia Pharmaceuticals Ltd Spray dispenser for opiod antagonists
ES2197792B1 (es) 1999-06-16 2005-05-01 Nastech Pharmaceutical Co., Inc. Formulaciones farmaceuticas que contienen morfina intranasal.
GB9924797D0 (en) 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US6284765B1 (en) 2000-04-27 2001-09-04 The University Of North Texas Health Science Center At Fort Worth (+) naloxone and epinephrine combination therapy
WO2002011778A1 (en) * 2000-05-10 2002-02-14 University Of Kentucky Research Foundation System and method for intranasal administration of opioids
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
DE60133203T3 (de) * 2000-07-31 2012-02-23 Nycomed Danmark Aps Fentanyl Zusammensetzung für nasale Anwendung
DE10064219B9 (de) 2000-12-22 2009-02-12 Nasalis Pain Relief International Gmbh Neue Fentanyl und/oder dessen Derivate enthaltende pharmazeutische Zusammensetzung zur nasalen Anwendung
US7666876B2 (en) * 2002-03-19 2010-02-23 Vernalis (R&D) Limited Buprenorphine formulations for intranasal delivery
CN1674903A (zh) 2002-07-11 2005-09-28 大鹏药品工业株式会社 经鼻吸收用组合物
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
CN1575795A (zh) * 2003-06-25 2005-02-09 中国人民解放军军事医学科学院毒物药物研究所 盐酸纳洛酮鼻腔喷雾剂
GB2403711A (en) * 2003-07-07 2005-01-12 Gw Pharma Ltd Drug dispenser with controlled access
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
CN1726915B (zh) * 2004-07-27 2013-04-24 中国人民解放军军事医学科学院毒物药物研究所 盐酸纳洛酮鼻腔给药系统或组合物及其制备方法
US8673360B2 (en) 2004-08-10 2014-03-18 Shin Nippon Biomedical Laboratories, Ltd. Compositions that enable rapid-acting and highly absorptive intranasal administration
CN100524037C (zh) * 2004-11-09 2009-08-05 皇家飞利浦电子股份有限公司 空间光调制器阵列和制造空间光调制器设备的方法
AU2005322305B2 (en) * 2004-12-23 2010-09-16 Roxro Pharma, Inc. Therapeutic compositions for intranasal administration of ketorolac
US8911751B2 (en) 2005-10-11 2014-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for nasal delivery
US20070212307A1 (en) * 2006-02-10 2007-09-13 Daniel Wermeling Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
RU2344822C2 (ru) * 2006-04-05 2009-01-27 Алексей Валентинович Надеждин Способ лечения героиновой наркомании
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
ES2611995T3 (es) * 2007-01-19 2017-05-11 Hananja Ehf Métodos y composiciones para el suministro de un agente terapéutico
WO2009040595A1 (en) 2007-09-28 2009-04-02 Wockhardt Research Centre Multi-dose pharmaceutical composition of analgesic for nasal administration
AR086391A1 (es) * 2011-05-13 2013-12-11 Euro Celtique Sa Formas de dosificacion farmaceutica intranasales que comprenden naloxona
CA2875384A1 (en) 2013-12-20 2015-06-20 AntiOP, Inc. Intranasal naloxone compositions and methods of making and using same
US10085937B2 (en) 2014-03-14 2018-10-02 Adapt Pharma Limited Nasal drug products and methods of their use
US9561177B2 (en) 2014-03-14 2017-02-07 Adapt Pharma Limited Nasal drug products and methods of their use
CN106163499A (zh) 2014-03-14 2016-11-23 欧皮安特制药有限公司 鼻用药物产品及其使用方法
US9480644B2 (en) 2014-03-14 2016-11-01 Opiant Pharmaceuticals, Inc. Nasal drug products and methods of their use
US10617686B2 (en) 2014-07-08 2020-04-14 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray

Also Published As

Publication number Publication date
NZ705933A (en) 2016-07-29
ME02958B (me) 2018-07-20
ES2661838T3 (es) 2018-04-04
MY194947A (en) 2022-12-27
PH12016501342A1 (en) 2018-06-11
LT2706982T (lt) 2018-05-25
BR112013029126A2 (pt) 2017-02-07
CN103764119A (zh) 2014-04-30
UA110974C2 (uk) 2016-03-10
TR201802716T4 (tr) 2018-03-21
RU2657441C1 (ru) 2018-06-13
RS57054B1 (sr) 2018-05-31
JP2016128453A (ja) 2016-07-14
NO2706982T3 (es) 2018-06-02
DK201800034U1 (da) 2018-05-25
AT16553U1 (de) 2020-01-15
AU2016204880B2 (en) 2017-11-23
PL2706982T3 (pl) 2018-07-31
JP2014513683A (ja) 2014-06-05
EP3320893A1 (en) 2018-05-16
KR20140007482A (ko) 2014-01-17
US20240082149A1 (en) 2024-03-14
AU2012257785B2 (en) 2016-04-14
NZ617442A (en) 2015-03-27
RU2587051C2 (ru) 2016-06-10
JP6110367B2 (ja) 2017-04-05
KR20170010078A (ko) 2017-01-25
US20150018379A1 (en) 2015-01-15
DK2706982T3 (en) 2018-03-12
US11020343B2 (en) 2021-06-01
AU2016204880A1 (en) 2016-07-28
EP2706982B2 (en) 2021-03-10
PH12016501342B1 (en) 2018-06-11
CN107260672A (zh) 2017-10-20
MX354249B (es) 2018-02-20
US20170304192A1 (en) 2017-10-26
JP2018150336A (ja) 2018-09-27
AU2012257785A1 (en) 2013-11-28
WO2012156317A3 (en) 2013-05-10
US20170231904A1 (en) 2017-08-17
KR101698182B1 (ko) 2017-01-19
TW201311244A (zh) 2013-03-16
DK2706982T4 (da) 2021-05-10
RU2013155479A (ru) 2015-06-20
CA2835940A1 (en) 2012-11-22
US11806428B2 (en) 2023-11-07
MX2013013276A (es) 2014-08-07
US20150126540A1 (en) 2015-05-07
US20190374464A1 (en) 2019-12-12
ZA201308280B (en) 2014-07-30
IL229409A0 (en) 2014-01-30
US20210338574A1 (en) 2021-11-04
WO2012156317A2 (en) 2012-11-22
DE202012013606U1 (de) 2018-04-18
CA2835940C (en) 2020-08-04
HRP20180233T1 (hr) 2018-06-01
SI2706982T1 (en) 2018-05-31
CY1120399T1 (el) 2019-07-10
AR086391A1 (es) 2013-12-11
HUE036465T2 (hu) 2018-07-30
ES2661838T5 (es) 2021-11-18
HK1255428A1 (zh) 2019-08-16
TWI486161B (zh) 2015-06-01
PT2706982T (pt) 2018-03-08
IL229409B (en) 2020-10-29
EP2706982B1 (en) 2018-01-03
KR101873174B1 (ko) 2018-06-29
EP2706982A2 (en) 2014-03-19
SG194927A1 (en) 2013-12-30

Similar Documents

Publication Publication Date Title
CO6821959A2 (es) Formas de dosificación farmacéutica intranasales que comprenden naloxona
CO6870021A2 (es) Conjunto dispensador
CO7010807A2 (es) Dispensador
CO7010828A2 (es) Preparación farmacéutica que comprende ߖciclodextrina sustituida
UA23653S (uk) Флакон для парфумів
UA22618S (uk) Пляшка
DOS2011000220S (es) Dispensador
UA22433S (uk) Пляшка
UA22432S (uk) Пляшка
UA22487S (uk) Пляшка
UA22720S (uk) Пляшка
UA22675S (uk) Пляшка
UA22652S (uk) Пляшка
UA22312S (uk) Флакон
UA22269S (uk) Флакон
UA22366S (uk) Пляшка
UA22710S (uk) Пляшка
UA22709S (uk) Пляшка
UA21953S (uk) Пляшка
UA22517S (uk) Пляшка
UA21943S (uk) Флакон
TH129439B (th) ขวด
UA22391S (uk) Пляшка
UA22392S (uk) Пляшка
UA22294S (uk) Пляшка

Legal Events

Date Code Title Description
FC Application refused